MAZDUTIDE™️ 30 MG

Balance. Metabolize. Transform.

Experience advanced metabolic research with MAZDUTIDE™️ 30 MG, a dual-receptor peptide investigated for its activity at both the GLP-1 (glucagon-like peptide-1) receptor and glucagon receptor (GCGR).

Designed to influence complementary metabolic pathways, Mazdutide has attracted significant research interest in body-weight regulation, appetite control, glucose metabolism, energy expenditure, and metabolic health.

---

The Science of Dual-Receptor Synergy

Mazdutide — 30 MG

Mazdutide is a synthetic peptide designed as a GLP-1/Glucagon dual receptor agonist.

Its two pathways have complementary metabolic roles:

• GLP-1 Receptor Activity: Associated with appetite and satiety signaling, glucose-dependent insulin secretion, and regulation of food intake.
• Glucagon Receptor Activity: Influences hepatic energy metabolism and has been investigated for its potential contribution to increased energy expenditure and lipid metabolism.

The result: Appetite regulation + metabolic control + body-weight management + energy-expenditure research.

---

Key Research Areas

• Supports appetite and satiety research
• Investigated for body-weight reduction
• Supports glucose-metabolism research
• Studied for metabolic health and insulin-sensitivity pathways
• Investigated for effects on energy expenditure
• Supports lipid-metabolism research
• Studied for reductions in body weight and waist circumference
• Investigated in obesity and metabolic-disease research
• Provides dual GLP-1 + glucagon receptor activity

---

Crafted for Advanced Metabolic Research

Designed for research focused on:

• Weight management
• Appetite regulation
• Metabolic health
• Glucose control
• Energy expenditure
• Body-composition research
• Obesity-related metabolic pathways
• Cardiometabolic risk factors

---

Product Details

Mazdutide

Dual GLP-1 / Glucagon Receptor Agonist
Total: 30 MG

• Mazdutide (30 MG): Appetite • Weight • Glucose • Metabolic Research

---

Advanced Metabolic Mechanism

Unlike single-pathway GLP-1 compounds, Mazdutide combines:

• GLP-1 → Appetite & glucose regulation
• Glucagon → Energy & lipid metabolism

This dual mechanism is being investigated as a strategy to influence both sides of weight management:
Energy Intake ↓ + Metabolic Energy Utilization ↑

---

Optimized Lifestyle Support

Metabolic outcomes are generally supported by:

• Adequate daily hydration
• Sufficient protein intake
• A balanced, nutrient-rich diet
• Regular resistance and cardiovascular exercise
• Quality sleep and recovery
• Monitoring nutritional intake during reduced appetite

---

Refined Protocol

Because Mazdutide is a pharmacologically active investigational compound, a universal self-directed dosing or injection protocol should not be inferred from research-product concentration alone.

Clinical-trial dosing, escalation schedules, and monitoring are specific to the studied pharmaceutical formulation and research protocol.

---

Clinical Research Perspective

Mazdutide has progressed beyond purely laboratory research and has been evaluated in human clinical trials, particularly for obesity and metabolic disorders.

Clinical studies have reported meaningful reductions in body weight and other metabolic measures at studied doses. Its dual GLP-1/glucagon mechanism distinguishes it from medications that act only through GLP-1 receptors.

However, results from clinical trials should not be interpreted as establishing that an independently supplied research formulation has the same quality, safety, pharmacokinetics, or clinical performance as the investigational pharmaceutical product used in those trials.

---

Possible Side Effects

In clinical research, commonly observed adverse effects have predominantly involved the gastrointestinal system and can include:

• Nausea
• Voming
• Diarrhea
• Reduced appetite
• Abdominal discomfort
• Constipation

Note: Individual responses can vary, and safety considerations depend on dose, medical history, concomitant medications, and other factors.

---

Why Choose Stayfit Pharma

When quality matters, precision defines the difference.

• High-purity research compounds
• Manufactured under strict quality standards
• Advanced formulations for metabolic research
• Premium-grade ingredients and quality control

---

MAZDUTIDE™️ 30 MG
Dual GLP-1 / Glucagon Receptor Agonist
Balance • Metabolize • Transform